Below is a complete list of all Transfusion Medicine Updates published from February 1992 to the present that are relevant to the Coagulation Laboratory.

 

 

2011

Issue #1	Dabigatran, a New Oral Anticoagulant & Its Role in Clinical Practice	Irina Chibisov, M.D. Andrea Cortese Hassett, Ph.D.

2010

No relevant issues.

2009

Issue #3

Clopidogrel (Plavix®) Monitoring

Andrea Cortese Hassett, Ph.D.

2008

No relevant issues.

                           

---

2007

---

Issue #6	Strategies for Reversal of Anticoagulants, Part 2: The Newer Anticoagulant Agents	Irina Chibisov, M.D.

Issue #5	Strategies for Reversal of Anticoagulants, Part I: Warfarin, Unfractionated Heparin and Low Molecular Weight Heparins	Irina Chibisov, M.D.

Issue #3	Von Willebrand Disease	Minh-Ha Tran, D.O.

Issue #2	Off-label use of Recombinant Factor VIIa (rFVIIa)	Suzanne Bakdash, M.D., M.P.H. Franklin A. Bontempo, M.D.

2006

Issue #4	Review of International Consensus Statement On An Update of the Classification Criteria for Definite Antiphospholipid Syndrome	Zella R. Zeigler, M.D

2005

Issue#4	Aspirin Resistance	Zella Zeigler, M.D.

2004

Issue #3	Quantitative D-dimer: Ruling out Venous Thrombosis	Andrea Cortese-Hassett, Ph.D.

2003

Issue #6	Hyperhomocysteinemia	Andrea Cortese Hassett Ph.D.

2002

Issue #5	Platelet Function Testing	Andrea Cortese Hassett, Ph.D.

Issue #4	New Therapy For Cold Autoimmune Hemolytic Anemia	Ram Kakaiya, M.D.

Issue #3	DIC, Sepsis, Inflammation and Activated Protein C (APC)	Kimberly Schlesinger, M.D. Margaret Ragni, M.D.

Issue #2	New Anticoagulants in Clinical Practice	Joseph E. Kiss, M.D.

Issue #1	Laboratory Evaluation of Thrombophilia in Recurrent Pregnancy Loss	Kathleen E. Puca, M.D.

2001

May	The Lupus Anticoagulant - An Update	Franklin A. Bontempo, M.D.

January	Activated Protein C Resistance	Andrea Cortese-Hassett, Ph.D. Franklin A. Bontempo, M.D.

2000

July	Closure Time Platelet Function Screening	Andrea Cortese Hassett, PhD. Franklin A. Bontempo, M.D.

February	D-dimer Testing and Acute Venous Thromboembolism	Andrea Cortese Hassett,Ph.D.

January	Antiplatelet Agents	Franklin A. Bontempo, M.D.

1999

November / December	RECOMBINANT FACTOR VIIa: A New Product for Factor VIII and IX Inhibitors	Margaret V. Ragni, M.D.

September	Platelet Transfusion Therapy	Darrell J. Triulzi, M.D.

May	Nucleic Acid Amplification Testing	Arell Shapiro, M.D.

March	Disseminated Intravascular Coagulation	Agnes Aysola, M.D. Ileana Lopez-Plaza, M.D.

February	Laboratory Monitoring of Anticoagulant Therapy	Andrea Cortese Hassett,Ph.D.

1998

August / September	Acquired Inhibitors to Factor VIII	Margaret Ragni, M.D.

June	The Prothrombin Variant	Franklin A. Bontempo, M.D.

February / March	Optimizing the INR to Improve Oral Anticoagulant Monitoring	Andrea Cortese Hassett, Ph.D.

January	New Anticoagulants	Franklin A. Bontempo, M.D

1997

August	Hereditary Hemachromatosis	Andrea Cortese Hassett, Ph.D. Joseph E. Kiss, M.D.

January	Heparin-Induced Thrombocytopenia	Franklin A. Bontempo, M.D.

1996

June	Low Molecular Weight Heparin	Franklin A. Bontempo, M.D. Andrea Cortese Hassett, Ph.D.

February	Heparin Monitoring	Andrea Cortese Hassett, Ph.D.

1995

August	The Factor V Leiden Mutation	Franklin A. Bontempo, M.D. Andrea Cortese Hassett, Ph.D.

June	The INR (International Normalized Ratio) For Monitoring Oral Anticoagulant Therapy	Andrea Cortese Hassett, Ph.D. Frank A. Bontempo, M.D.

1994

November	The Activated Protein C Resistance Test	Franklin A. Bontempo, M.D. Andrea Cortese Hassett, Ph.D.

October	von Willebrand Disease	Margaret V. Ragni, M.D., M.P.H.

April	Use and Misuse of the Bleeding Time	Franklin A. Bontempo, M.D.

1992

December	The Lupus Anticoagulant	Franklin A. Bontempo, M.D.

November	Newer Approaches to Treatment of Hemophilia and von Willebrand's Disease	Margaret V. Ragni, M.D.